Dengue virus protease inhibitors
Dengue virus (DENV) is a major health threat that affects 2.5 billion people, or 40% of the world’s population. However, there are no approved antiviral drugs or vaccines to treat Dengue infection. This thesis describes the design, synthesis and discovery of a new class of inhibitors of DENV NS3 pro...
Main Author: | Tiew, Kok-Chuan |
---|---|
Other Authors: | Groutas, William C. |
Format: | Others |
Language: | en_US |
Published: |
Wichita State University
2013
|
Subjects: | |
Online Access: | http://hdl.handle.net/10057/6117 |
Similar Items
-
Dengue virus and West Nile virus protease inhibitors
by: Aravapalli, Sridhar
Published: (2013) -
Potential inhibitors of dengue and West Nile virus proteases
by: Mohan, Swathi
Published: (2007) -
Mammalian and viral protease inhibitors
by: Dou, Dengfeng
Published: (2010) -
Design, synthesis, and biochemical evaluation of novel inhibitors of Norwalk virus 3CL protease
by: Mandadapu, Sivakoteswara Rao
Published: (2014) -
Novel mechanism-based inhibitors of serine proteases
by: Gan, Xiangdong
Published: (2007)